Showing results (251-260 of 321) with videos related to
Sort By:
Pageof 33
Cancer Research|February 20, 2004
Hypoxia targeted gene therapy to increase the efficacy of tirapazamine as an adjuvant to radiotherapy: reversing tumor radioresistance and effecting cureRachel L Cowen, Kaye J Williams, Edwin C Chinje, et al.Biochemical Pharmacology|September 25, 2003
3-substituted-5-aziridinyl-1-methylindole-4,7-diones as NQO1-directed antitumour agents: mechanism of activation and cytotoxicity in vitroMohammed Jaffar, Roger M Phillips, Kaye J Williams, et al.International Journal of Oncology|May 5, 2005
Hypoxia-regulated glucose transporter Glut-1 may influence chemosensitivity to some alkylating agents: results of EORTC (First Translational Award) study of the relevance of tumour hypoxia to the outcome of chemotherapy in human tumour-derived xenograftsR E Airley, R M Phillips, A E Evans, et al.British Journal of Cancer|July 24, 2008
Reciprocal relationship between expression of hypoxia inducible factor 1alpha (HIF-1alpha) and the pro-apoptotic protein bid in ex vivo colorectal cancerM M Seenath, D Roberts, C Cawthorne, et al.Molecular Cancer Therapeutics|October 6, 2011
Inhibition of PARP-1 by olaparib (AZD2281) increases the radiosensitivity of a lung tumor xenograftJoana M Senra, Brian A Telfer, Kim E Cherry, et al.Anti-Cancer Drug Design|July 1, 1996
Chirality of a 1,10-bisacetoxymitosene compound. Impact on reductive activation, DNA interstrand cross-linking and antitumour activityM Maliepaard, S E Groot, N J de Mol, et al.The Australian and New Zealand Journal of Psychiatry|January 11, 2021
Paranoia in patients attending child and adolescent mental health servicesJessica C Bird, Emma C Fergusson, Miriam Kirkham, et al.International Journal of Radiation Oncology, Biology, Physics|April 27, 2005
Dual responsive promoters to target therapeutic gene expression to radiation-resistant hypoxic tumor cellsNaomi Chadderton, Rachel L Cowen, Freda C D Sheppard, et al.The British Journal of Radiology|September 19, 2006
Developments in and experience of kilovoltage X-ray cone beam image-guided radiotherapyC J Moore, A Amer, T Marchant, et al.Cancer Research|April 23, 1999
Nitric oxide synthases catalyze the activation of redox cycling and bioreductive anticancer agentsA P Garner, M J Paine, I Rodriguez-Crespo, et al.Pageof 33